戻る Agenda
S33 : Current Status and Issues of Pharmaceutical Venture Support Based on Efforts to Improve Pharmaceutical Regulations (RA)
Session Chair(s)
Yasuko Terao, PhD
Head, External Scientific Engagement, R&D Japan Region,
Takeda Pharmaceutical Co., Ltd., Japan
Speaker(s)
Toshio Fujimoto
Ipark institute, Japan
President
Tadahisa Kagimoto
Healios K.K, Japan
Chairman and CEO
Tadayuki Mizutani
MHLW Medical Policy Bureau, Japan
Pharmaceutical Vencure promotion and Medical information Planning Division
Jun Kusunoki
Jhonson and Jhonson innovation, Japan
Innovation Early Innovation partnaring, Sinior Director, Japan countory lead